Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects (Q43915939)

28 November 2017

Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects (English)

1 reference

28 November 2017

Mary Jeanne DeLeon

1

1 reference

28 November 2017

Vikram Chandurkar

series ordinal

2

1 reference

28 November 2017

Stewart G Albert

series ordinal

3

1 reference

28 November 2017

Arshag D Mooradian

series ordinal

4

1 reference

28 November 2017

1 May 2002

1 reference

Diabetes Research and Clinical Practice

28 November 2017

1 reference

28 November 2017

56

1 reference

28 November 2017

101-106

1 reference

28 November 2017

2

1 reference

Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

The ageing entero-insular axis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Drug therapy of non-insulin-dependent diabetes mellitus in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Dose-response profile of acarbose in older subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

The postprandial state and the risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900359-X

7 January 2021

10.1016/S0168-8227(01)00359-X

Identifiers

DOI

1 reference

28 November 2017

1 reference